Full Press Release Details
To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S.
Gan, Israel, Jan. 21, 2026 /PRNewswire/ - Pulsenmore Ltd. (NASDAQ, TASE: PLSM), a pioneer in home ultrasound
technology, today announced that
its shares will begin trading on Nasdaq at the U.S. market open today. The Company's shares will trade under the
ticker symbol PLSM on the Nasdaq Capital Market as well as the Tel Aviv Stock Exchange (TASE).
is a digital health company developing home-use ultrasound and telehealth technology that enables physician-supervised prenatal monitoring
outside traditional clinical settings. Its platform combines proprietary ultrasound hardware, secure cloud-based image transmission,
and clinical review workflows to improve access, continuity of care, and patient experience.
Company operates in select international markets in collaboration with healthcare systems and providers. Pulsenmore has received FDA
authorization for its home-use prenatal ultrasound system, establishing a regulatory foundation for potential future commercialization
in the United States.
offers the first and only FDA-authorized home-use prenatal ultrasound system,"
said Dr. Elazar Sonnenschein, CEO and founder of Pulsenmore. "As we accelerate our expansion across the U.S. healthcare
system and deepen our engagement with leading medical centers and hospitals nationwide, our Nasdaq listing marks a transformative step
in the Company's evolution. We expect this milestone will
enhance long-term shareholder value by increasing visibility and liquidity, while providing a powerful platform to attract a broader,
global investor base aligned with our growth strategy and mission."
Ltd. is dedicated to revolutionizing maternal health through the development of home-use ultrasound technology that connect mothers and
healthcare providers remotely. By leveraging advanced imaging and telemedicine, Pulsenmore makes prenatal care patient-centric, expanding
access and improving continuity of care. For more information, visit www.pulsenmore.com
press release contains forward-looking statements. In particular, statements using words such as "may," "seek,"
"will," "consider," "likely," "assume," "estimate," "expect,"
"anticipate," "intend," "believe," "contemplate," "do not believe," "aim,"
"goal," "due," "predict," "plan," "project," "continue," "potential,"
"positioned," "guidance," "objective," "outlook," "trends," "future,"
"could," "would," "should," "target," "on track" or their negatives or variations,
and similar terminology and words of similar import, generally involve future or forward-looking statements. Such forward-looking statements
include, but are not limited to, statements relating to the expected time for Pulsenmore's ordinary shares to begin trading on
the Nasdaq and Pulsenmore's expectation that the listing of its ordinary shares on the Nasdaq Stock Exchange will enhance long-term
shareholder value. Forward-looking statements reflect Pulsenmore's current views, plans, or expectations with respect to future
events or financial performance. They are inherently subject to significant business, economic, competitive, and other risks, uncertainties,
and contingencies. Forward-looking statements are based on Pulsenmore's current expectations and are subject to inherent uncertainties,
risks and assumptions that are difficult to predict, including, but not limited to, the following: the Company's lack of operating
history; the Company's current and future capital requirements and the Company's belief that its existing cash will be sufficient
to fund its operations for more than one year from the date that the financial statements are issued; the Company's ability to
manufacture, market and sell its products and to generate revenues; the Company's ability to maintain its relationships with key
partners and grow relationships with new partners; the Company's ability to maintain or protect the validity of its U.S. and other
patents and other intellectual property; the Company's ability to launch and penetrate markets in new locations and new market
segments; the Company's ability to retain key executive members and hire additional personnel; the Company's ability to maintain
and expand intellectual property rights; interpretations of current laws and the passages of future laws; the Company's ability
to achieve greater regulatory compliance needed in existing and new markets; the Company's ability to achieve key performance milestones
in its planned operational testing; the Company's ability to establish adequate sales, marketing and distribution channels; security,
political and economic instability in the Middle East that could harm its business; and acceptance of the Company's business model
by investors. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate.
For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company's reports
filed from time to time with the SEC, including, but not limited to, the risks, uncertainties and other factors included in the Company's
Form 20-F (SEC File No. 001-43033), filed with the SEC on December 29, 2025. The inclusion of forward-looking statements in this or any
other communication should not be considered as a representation by Pulsenmore or any other person that current plans or expectations
will be achieved. Forward-looking statements speak only as of the date on which they are made, and Pulsenmore undertakes no obligation
to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise,
except as otherwise required by law.